Body Vision Medical Awarded Agreement with Premier, Inc.
"We are honored by Premier's recognition of our commitment to elevating patient care through the democratization of innovative technologies and that our mission to enable better care and outcomes at a lower cost aligns with theirs," says
Body Vision Medical's LungVision™ system uses artificial intelligence (AI) to transform X-ray images from any C-arm into real-time, intraoperative CT scans. This empowers bronchoscopists to biopsy from smaller, more difficult-to-access lung lesions at an earlier stage, thus maximizing the likelihood of an early diagnosis for lung cancer patients and improving odds for survival.
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,350
About Body Vision Medical
Body Vision Medical believes in saving lives through the democratization of innovative medical technology and the Quintuple Aim is at the heart of everything that we do. Our first commercial product, LungVision™, provides AI-powered real-time image guidance to address the unmet clinical need for early, definitive lung cancer diagnosis and, in the future, to enable effective treatment of lung lesions via a minimally-invasive procedure.
Visit bodyvisionmedical.com to learn more and connect with us on LinkedIn.
Contact
[email protected]
+1-888-302-5439
View original content to download multimedia:https://www.prnewswire.com/news-releases/body-vision-medical-awarded-agreement-with-premier-inc-301972216.html
SOURCE Body Vision Medical
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASADOR ETXEBARRI IS NAMED NO.1 IN THE LIST OF THE 50 BEST RESTAURANTS 2026
- GAC Exports 223,000 Units in Jan-Oct, Setting a New Record! Steadily Advancing High-Quality Globalization
- Dohop Introduces TravelSure, a Disruption-Recovery Service for OTAs, Travel Sellers and Airlines
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share